Collegeville, PA, United States of America

Yao-Bin Liu

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: **Innovator Spotlight: Yao-Bin Liu's Impact on Biomedicine**

Introduction

Yao-Bin Liu, located in Collegeville, PA, is a prominent inventor known for his significant contributions to the field of biomedicine. With a total of four patents to his name, Liu has made notable advances in the development of innovative therapies aimed at treating critical health issues.

Latest Patents

Among Liu's most recent patents are groundbreaking developments related to ICOS binding proteins. These inventions focus on an ICOS binding protein or an antigen-binding portion that acts as an agonist to human ICOS. Importantly, these proteins do not induce complement, antibody-dependent cellular cytotoxicity (ADCC), or complement-dependent cytotoxicity (CDC) when in contact with T cells in vivo. The application of these proteins extends to methods for treating cancer, infectious diseases, and sepsis. Furthermore, the ICOS binding proteins have the capability of activating T cells, stimulating their proliferation, and inducing cytokine production upon interaction.

Career Highlights

Liu's work at GlaxoSmithKline Intellectual Property Development Limited has positioned him as a vital member of the research team. His innovative spirit and dedication to research have allowed him to contribute significantly to the company's mission of advancing healthcare through science and technology.

Collaborations

In his career, Liu has collaborated with esteemed colleagues, including Patrick A. Mayes and Radha Shah Parmar. These partnerships highlight the collaborative nature of biomedical research and its impact on successful innovation.

Conclusion

Yao-Bin Liu stands as a significant figure in the realm of biotechnology, with his patents exemplifying the intersection of science and healthcare innovation. His pioneering work on ICOS binding proteins will undoubtedly contribute to advancements in therapeutic treatments and improve patient outcomes in various critical areas.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…